{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:56:08Z","timestamp":1790790968880,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Renal function may be overestimated in patients with hepatic dysfunction because of reduced creatinine production; however, its impact on the vancomycin dosing regimen is unclear. In this study, the characteristics of steady-state vancomycin area under the concentration\u2013time curve (AUC\n                      <jats:sub>ss<\/jats:sub>\n                      ) estimation and optimal strategies for its clinical management were determined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This multicenter, retrospective, observational study included adult patients who received vancomycin between January 2018 and December 2023; trough concentrations were measured. Patients with albumin levels of &lt;2 g\/dL with hepatic dysfunction were defined as having cirrhosis, hepatic failure, or other hepatic dysfunctions. A deviation of \u226530% in the AUC\n                      <jats:sub>ss<\/jats:sub>\n                      ratio, calculated as the Bayesian-estimated AUC using trough concentrations divided by the AUC derived from population pharmacokinetic parameters, was considered attributable to hepatic dysfunction. Multivariate analysis was conducted to calculate the adjusted odds ratio (aOR) and 95% confidence interval (CI) for factors associated with an AUC\n                      <jats:sub>ss<\/jats:sub>\n                      deviation of \u226530%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In total, 157 patients (63 with and 94 without hepatic dysfunction) were included in the study. Multivariate analysis identified hepatic dysfunction (aOR, 2.257; 95% CI, 1.104\u20134.618) and creatinine clearance (aOR, 1.016; 95% CI, 1.006\u20131.027) as factors associated with an AUC\n                      <jats:sub>ss<\/jats:sub>\n                      deviation of \u226530%. Patients with hepatic dysfunction had higher AUC\n                      <jats:sub>ss<\/jats:sub>\n                      and steady-state trough ratios (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.017, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Early therapeutic drug monitoring may be beneficial in patients with hepatic dysfunction because deviations of \u226530% between population-based and Bayesian AUC estimates have been observed in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001525","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:01:43Z","timestamp":1790787703000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Hepatic Dysfunction on Vancomycin Area Under the Concentration\u2013Time Curve Estimation and the Need for Early Therapeutic Drug Monitoring"],"prefix":"10.1097","author":[{"given":"Takaya","family":"Namiki","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hanai","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiju","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Hanawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kameda Medical Center, Kamogawa, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hashi","sequence":"additional","affiliation":[{"name":"Minato Pharmacy, Urayasu, Chiba, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Asakawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kameda Medical Center, Kamogawa, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riku","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kameda Medical Center, Kamogawa, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Tsujimura","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kameda Medical Center, Kamogawa, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Enoki","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurika","family":"Mizoguchi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Chiba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"R1-20260930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"R2-20260930","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R3-20260930","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R4-20260930","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"R5-20260930","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"R6-20260930","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health-syst Pharm"},{"key":"R7-20260930","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/pharmaceutics14030489","article-title":"Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"14","author":"Matsumoto","year":"2022","journal-title":"Pharmaceutics"},{"key":"R8-20260930","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11095-021-03030-y","article-title":"Conductance of area under the concentration\u2013time curve estimations of vancomycin with limited sampling by a newly-developed web application","volume":"38","author":"Oda","year":"2021","journal-title":"Pharm Res"},{"key":"R9-20260930","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"R10-20260930","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol Rev"},{"key":"R11-20260930","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1111\/j.1742-4658.2008.06718.x","article-title":"Enzymes of creatine biosynthesis, arginine, and methionine metabolism in normal and malignant cells","volume":"275","author":"Bera","year":"2008","journal-title":"FEBS J"},{"key":"R12-20260930","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/ajkd.2003.50035","article-title":"Assessing renal function in cirrhotic patients: problems and pitfalls","volume":"41","author":"Sherman","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R13-20260930","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1093\/ndt\/gfq248","article-title":"What is the best alternative to inulin clearance to estimate GFR in patients with decompensated alcoholic cirrhosis?","volume":"25","author":"Rognant","year":"2010","journal-title":"Nephrol Dial Transpl"},{"key":"R14-20260930","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ndt\/gfi305","article-title":"Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patients","volume":"21","author":"P\u00f6ge","year":"2006","journal-title":"Nephrol Dial Transpl"},{"key":"R15-20260930","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1155\/2006\/858053","article-title":"Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?","volume":"20","author":"MacAulay","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"R16-20260930","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0002-9343(87)90156-2","article-title":"Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study","volume":"82","author":"Papadakis","year":"1987","journal-title":"Am J Med"},{"key":"R17-20260930","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jceh.2021.11.004","article-title":"Value of liver function tests in cirrhosis","volume":"12","author":"Sharma","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"R18-20260930","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/07853890.2019.1693056","article-title":"Impaired albumin function: a novel potential indicator for liver function damage?","volume":"51","author":"Sun","year":"2019","journal-title":"Ann Med"},{"key":"R19-20260930","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jhep.2022.09.001","article-title":"Loss of liver function in chronic liver disease: an identity crisis","volume":"78","author":"Berasain","year":"2023","journal-title":"J Hepatol"},{"key":"R20-20260930","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5604\/01.3001.0012.0916","article-title":"New insights about albumin and liver disease","volume":"17","author":"Carvalho","year":"2018","journal-title":"Ann Hepatol"},{"key":"R21-20260930","doi-asserted-by":"crossref","first-page":"108489","DOI":"10.1016\/j.ejso.2024.108489","article-title":"Biliary tract cancer","volume":"51","author":"S\u00f8reide","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"R22-20260930","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0039-6109(16)45285-0","article-title":"Acute cholangitis","volume":"70","author":"Lipsett","year":"1990","journal-title":"Surg Clin North Am"},{"key":"R23-20260930","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"R25-20260930","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/0018578718772266","article-title":"Evaluation of vancomycin dosing in patients with cirrhosis: beginning de-liver-ations about a new nomogram","volume":"54","author":"Regal","year":"2019","journal-title":"Hosp Pharm"},{"key":"R26-20260930","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12941-020-00354-2","article-title":"The risk of vancomycin toxicity in patients with liver impairment","volume":"19","author":"Brunetti","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R27-20260930","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R28-20260930","first-page":"327","article-title":"The assessment of liver disease utilizing a panel of liver function tests","volume":"2","author":"Assiri","year":"2022","journal-title":"Int J Pharm Bio-Med Sci"},{"key":"R29-20260930","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/cts.13626","article-title":"Model-informed precision dosing of vancomycin for rapid achievement of target area under the concentration\u2013time curve: a simulation study","volume":"16","author":"Oda","year":"2023","journal-title":"Clin Transl Sci"},{"key":"R30-20260930","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jiac.2024.05.014","article-title":"Validation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web application","volume":"30","author":"Oda","year":"2024","journal-title":"J Infect Chemother"},{"key":"R31-20260930","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0016-5085(19)33181-6","article-title":"Albumin synthesis by human liver cells: its morphological demonstration","volume":"63","author":"Feldmann","year":"1972","journal-title":"Gastroenterology"},{"issue":"suppl 3","key":"R32-20260930","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11739-012-0802-0","article-title":"Hypoalbuminemia","volume":"7","author":"Gatta","year":"2012","journal-title":"Intern Emerg Med"},{"key":"R33-20260930","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00007691-199804000-00003","article-title":"Population pharmacokinetics of vancomycin in Japanese adult patients","volume":"20","author":"Yasuhara","year":"1998","journal-title":"Ther Drug Monit"},{"key":"R34-20260930","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.3748\/wjg.15.4653","article-title":"Spectrum of anemia associated with chronic liver disease","volume":"15","author":"Gonzalez-Casas","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R35-20260930","first-page":"272","article-title":"Association of liver cirrhosis severity with anemia: does it matter?","volume":"33","author":"Singh","year":"2020","journal-title":"Ann Gastroenterol"},{"key":"R36-20260930","doi-asserted-by":"crossref","first-page":"102821","DOI":"10.1016\/j.jiac.2025.102821","article-title":"Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoring","volume":"31","author":"Suzuki","year":"2025","journal-title":"J Infect Chemother"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:01:48Z","timestamp":1790787708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001525","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"2026-04-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}